189 related articles for article (PubMed ID: 9658074)
1. Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells.
Pise-Masison CA; Radonovich M; Sakaguchi K; Appella E; Brady JN
J Virol; 1998 Aug; 72(8):6348-55. PubMed ID: 9658074
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein.
Pise-Masison CA; Choi KS; Radonovich M; Dittmer J; Kim SJ; Brady JN
J Virol; 1998 Feb; 72(2):1165-70. PubMed ID: 9445014
[TBL] [Abstract][Full Text] [Related]
3. HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity.
Jeong SJ; Radonovich M; Brady JN; Pise-Masison CA
Blood; 2004 Sep; 104(5):1490-7. PubMed ID: 15155458
[TBL] [Abstract][Full Text] [Related]
4. Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells.
Jeong SJ; Pise-Masison CA; Radonovich MF; Park HU; Brady JN
Oncogene; 2005 Oct; 24(44):6719-28. PubMed ID: 16007163
[TBL] [Abstract][Full Text] [Related]
5. Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function.
Mahieux R; Pise-Masison CA; Lambert PF; Nicot C; De Marchis L; Gessain A; Green P; Hall W; Brady JN
J Virol; 2000 Aug; 74(15):6866-74. PubMed ID: 10888626
[TBL] [Abstract][Full Text] [Related]
6. p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells.
Takemoto S; Trovato R; Cereseto A; Nicot C; Kislyakova T; Casareto L; Waldmann T; Torelli G; Franchini G
Blood; 2000 Jun; 95(12):3939-44. PubMed ID: 10845931
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of p53 by HTLV type 1 and HTLV type 2 Tax trans-activators.
Mahieux R; Pise-Masison CA; Nicot C; Green P; Hall WW; Brady JN
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1677-81. PubMed ID: 11080809
[TBL] [Abstract][Full Text] [Related]
8. Human T-lymphotropic virus type I Tax protein utilizes distinct pathways for p53 inhibition that are cell type-dependent.
Pise-Masison CA; Mahieux R; Radonovich M; Jiang H; Brady JN
J Biol Chem; 2001 Jan; 276(1):200-5. PubMed ID: 11036071
[TBL] [Abstract][Full Text] [Related]
9. Insights into the molecular mechanism of p53 inhibition by HTLV type 1 Tax.
Pise-Masison CA; Mahieux R; Radonovich M; Jiang H; Duvall J; Guillerm C; Brady JN
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1669-75. PubMed ID: 11080808
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I.
Reid RL; Lindholm PF; Mireskandari A; Dittmer J; Brady JN
Oncogene; 1993 Nov; 8(11):3029-36. PubMed ID: 8414503
[TBL] [Abstract][Full Text] [Related]
11. Tax protein of HTLV-1 inhibits CBP/p300-mediated transcription by interfering with recruitment of CBP/p300 onto DNA element of E-box or p53 binding site.
Suzuki T; Uchida-Toita M; Yoshida M
Oncogene; 1999 Jul; 18(28):4137-43. PubMed ID: 10435595
[TBL] [Abstract][Full Text] [Related]
12. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2.
Dumaz N; Meek DW
EMBO J; 1999 Dec; 18(24):7002-10. PubMed ID: 10601022
[TBL] [Abstract][Full Text] [Related]
13. Small-molecule inhibitor which reactivates p53 in human T-cell leukemia virus type 1-transformed cells.
Jung KJ; Dasgupta A; Huang K; Jeong SJ; Pise-Masison C; Gurova KV; Brady JN
J Virol; 2008 Sep; 82(17):8537-47. PubMed ID: 18550670
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression and function of p53 in T-cells immortalized by HTLV-I Tax1.
Akagi T; Ono H; Tsuchida N; Shimotohno K
FEBS Lett; 1997 Apr; 406(3):263-6. PubMed ID: 9136898
[TBL] [Abstract][Full Text] [Related]
15. The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein.
Forlani G; Abdallah R; Accolla RS; Tosi G
J Virol; 2016 Jan; 90(7):3708-21. PubMed ID: 26792751
[TBL] [Abstract][Full Text] [Related]
16. Functional inactivation of wild-type p53 protein correlates with loss of IL-2 dependence in HTLV-I transformed human T lymphocytes.
Gartenhaus RB; Wang P
Leukemia; 1995 Dec; 9(12):2082-6. PubMed ID: 8609720
[TBL] [Abstract][Full Text] [Related]
17. Activation and regulation of interferon regulatory factor 4 in HTLV type 1-infected T lymphocytes.
Sharma S; Mamane Y; Grandvaux N; Bartlett J; Petropoulos L; Lin R; Hiscott J
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1613-22. PubMed ID: 11080800
[TBL] [Abstract][Full Text] [Related]
18. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
[TBL] [Abstract][Full Text] [Related]
19. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.
Shieh SY; Ikeda M; Taya Y; Prives C
Cell; 1997 Oct; 91(3):325-34. PubMed ID: 9363941
[TBL] [Abstract][Full Text] [Related]
20. Studies of the immortalizing activity of HTLV type 1 Tax, using an infectious molecular clone and transgenic mice.
Ratner L; Portis T; Robek M; Harding J; Grossman W
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1647-51. PubMed ID: 11080805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
